Tan Min-Yi, Huang Yong-Lan, Li Bei, Jiang Xiang, Chen Qian-Yu, Jia Xue-Fang, Tang Cheng-Fang, Liu Li
Guangzhou Newborn Screening Center, Guangzhou Women and Children's Medical Center, Guangzhou 510180, China.
Zhongguo Dang Dai Er Ke Za Zhi. 2017 Jan;19(1):59-63. doi: 10.7499/j.issn.1008-8830.2017.01.009.
To investigate the characteristics of DUOXA2 gene mutation and the genotype-phenotype relationship in children with congenital hypothyroidism (CH) in Guangzhou, China.
A total of 20 CH patients with suspected thyroid dyshormonogenesis who had no DUOX2 gene mutation were enrolled. These patients who were born between 2011 and 2012 were screened and diagnosed with CH in the Guangzhou Newborn Screening Center. PCR and direct sequencing were used to analyze DUOXA2 gene mutation.
Among the 20 patients, 2 had p.Y246X/p.Y246X homozygous mutation; 4 had monoallelic heterozygous mutation, among whom 2 carried the known pathogenic mutation c.413-414insA, 1 carried p.Y246X, and 1 carried a novel mutation, p.G79R. Reevaluation was performed at the age of 2-3 years, and the results showed that the two patients with p.Y246X/p.Y246X homozygous mutation were manifested as transient and mild permanent CH, respectively. Among the four patients with monoallelic heterozygous mutation, the one who carried p.Y246X mutation was manifested as typical permanent CH, and the other three were manifested as transient CH.
DUOXA2 gene mutation is a common molecular pathogenic basis for CH children with suspected thyroid dyshormonogenesis in Guangzhou, and most of them are manifested as transient CH. There is no association between DUOXA2 genotypes and phenotypes. The novel mutation p.G79R is probably a pathogenic mutation.
探讨中国广州先天性甲状腺功能减退症(CH)患儿DUOXA2基因突变特征及基因型与表型的关系。
纳入20例疑诊甲状腺激素合成障碍的CH患者,这些患者无DUOX2基因突变。这些于2011年至2012年出生的患者在广州新生儿筛查中心接受筛查并诊断为CH。采用聚合酶链反应(PCR)和直接测序法分析DUOXA2基因突变。
20例患者中,2例有p.Y246X/p.Y246X纯合突变;4例有单等位基因杂合突变,其中2例携带已知致病突变c.413 - 414insA,1例携带p.Y246X,1例携带新突变p.G79R。在2 - 3岁时进行重新评估,结果显示,2例p.Y246X/p.Y246X纯合突变患者分别表现为暂时性和轻度永久性CH。在4例单等位基因杂合突变患者中,携带p.Y246X突变的1例表现为典型永久性CH,其他3例表现为暂时性CH。
DUOXA2基因突变是广州疑诊甲状腺激素合成障碍的CH患儿常见的分子致病基础,且大多数表现为暂时性CH。DUOXA2基因型与表型之间无关联。新突变p.G79R可能是致病突变。